We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-3.84%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$6.16B
AUM Growth
+$1.7B
Cap. Flow
+$2.17B
Cap. Flow %
35.15%
Top 10 Hldgs %
26.62%
Holding
7,028
New
630
Increased
3,221
Reduced
2,151
Closed
574

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$204M
2
MSFT icon
Microsoft
MSFT
+$195M
3
AMZN icon
Amazon
AMZN
+$97.4M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$95M
5
TSM icon
TSMC
TSM
+$69.5M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$53M
2
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$26.7M
3
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$23.7M
4
IWD icon
iShares Russell 1000 Value ETF
IWD
+$19.5M
5
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$15M

Sector Composition

Rank Sector Weight
1 Technology 27%
2 Healthcare 10.88%
3 Consumer Discretionary 10.71%
4 Financials 8.69%
5 Communication Services 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NRXP icon
4551
NRX Pharmaceuticals
NRXP
$143M
$10K ﹤0.01%
1,294
+889
+220% +$5.99K
NSYS icon
4552
Nortech Systems
NSYS
$42.5M
$10K ﹤0.01%
922
-710
-44% -$8.88K
NXGL icon
4553
NexGel
NXGL
$4.51M
$10K ﹤0.01%
6,768
+6,463
+2,119% +$11.5K
ORBS
4554
Eightco Holdings
ORBS
$292M
$10K ﹤0.01%
57
+44
+338% +$10.5K
IMDX
4555
Insight Molecular Diagnostics
IMDX
$147M
$10K ﹤0.01%
675
-58
-8% -$1K
OPAD icon
4556
Offerpad Solutions
OPAD
$22.5M
$10K ﹤0.01%
55
-15
-21% -$4.04K
OPAL icon
4557
OPAL Fuels
OPAL
$67.1M
$10K ﹤0.01%
1,155
+860
+292% +$8.34K
ORLA
4558
DELISTED
Orla Mining
ORLA
$10K ﹤0.01%
2,916
-4,136
-59% -$12.7K
OUST icon
4559
Ouster
OUST
$3.25B
$10K ﹤0.01%
1,056
-1,124
-52% -$17.3K
OXLC
4560
Oxford Lane Capital
OXLC
$950M
$10K ﹤0.01%
400
-7
-2% -$211
PBFS icon
4561
Pioneer Bancorp
PBFS
$419M
$10K ﹤0.01%
1,111
-87
-7% -$839
PCSA icon
4562
Processa Pharmaceuticals
PCSA
$8.58M
$10K ﹤0.01%
9
+6
+200% +$8.82K
PDI icon
4563
PIMCO Dynamic Income Fund
PDI
$7.33B
$10K ﹤0.01%
517
-557
-52% -$11.7K
PPTA
4564
Perpetua Resources
PPTA
$3.1B
$10K ﹤0.01%
4,848
+3,997
+470% +$10.5K
PROK icon
4565
ProKidney
PROK
$289M
$10K ﹤0.01%
1,085
+432
+66% +$3.76K
PRQR icon
4566
ProQR Therapeutics
PRQR
$262M
$10K ﹤0.01%
13,274
-4,883
-27% -$3.92K
PULM icon
4567
Pulmatrix
PULM
$5.84M
$10K ﹤0.01%
2,707
-103
-4% -$459
RMTI icon
4568
Rockwell Medical
RMTI
$29.6M
$10K ﹤0.01%
772
+447
+138% +$6.77K
HIND
4569
Vyome Holdings
HIND
$15.6M
– –
0
– –
SABS icon
4570
SAB Biotherapeutics
SABS
$341M
$10K ﹤0.01%
1,364
+546
+67% +$5.42K
SAP icon
4571
SAP
SAP
$242B
$10K ﹤0.01%
129
-7,020
-98% -$620K
OLOX
4572
Olenox Industries
OLOX
$4.14M
$10K ﹤0.01%
1
– –
SHG icon
4573
Shinhan Financial Group
SHG
$34.6B
$10K ﹤0.01%
+425
New +$11.3K
SKYH icon
4574
Sky Harbour Group
SKYH
$379M
$10K ﹤0.01%
2,679
+2,584
+2,720% +$12.2K
SNOA icon
4575
Sonoma Pharmaceuticals
SNOA
$6.56M
$10K ﹤0.01%
246
+220
+846% +$12.9K
181 182
183
184 185

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2022 Portfolio in Review

As of Q3 2022, Tower Research Capital (TRC) held 7,028 positions worth $6.16B, up 38% from $4.46B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $2.17B of net new capital in Q3 2022, opening 630 new positions and adding to 3,221 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $53M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2022 buy was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.
  • Tower Research Capital (TRC) added most to Apple in Q3 2022, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $53M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Portfolio S&P 500 ETF in Q3 2022, selling an estimated $6.39M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $6.16B portfolio in Q3 2022.
  • Tower Research Capital (TRC) opened 630 new positions and closed 574 in Q3 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 38% quarter-over-quarter to $6.16B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2022, filed 10 Nov 2022.